DIG
OKYO

Dauntless Investment Group’s OKYO Pharma OKYO Stock Holding History

Dauntless Investment Group’s Portfolio OKYO Stock Details OKYO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.15K Sell
3,819
-467,704
-99% -$908K ﹤0.01% 60
2025
Q4 		$746K Sell
471,523
-1,950,525
-81% -$4.23M 0.59% 27
2025
Q3 		$4.84M Sell
2,422,048
-313,732
-11% -$799K 3.03% 9
2025
Q2 		$1.39M Buy
2,735,780
+747,000
+38% +$1.27M 2.41% 5
2025
Q1 		$2.53M Buy
+1,988,780
New +$2.38M 2.96% 9

Other funds holding OKYO

WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Dauntless Investment Group's OKYO Position: Q1 2026 in Review

Dauntless Investment Group reduced its OKYO Pharma (OKYO) stake by 99% in Q1 2026, selling an estimated $908K and leaving 3,819 shares worth $6.15K. The position accounts for ﹤0.01% of the portfolio, ranked #60.

Dauntless Investment Group first reported a position in OKYO in Q1 2025 and has held it in 5 quarters since. The position peaked at $4.84M in Q3 2025. 12 funds tracked by Wall St. Rank hold OKYO as of Q1 2026.

  • Dauntless Investment Group held 3,819 shares of OKYO Pharma worth $6.15K as of Q1 2026.
  • Dauntless Investment Group sold 467,704 OKYO Pharma shares in Q1 2026, an estimated $908K.
  • OKYO Pharma made up ﹤0.01% of Dauntless Investment Group's portfolio in Q1 2026, its #60 holding.
  • Dauntless Investment Group first reported a position in OKYO Pharma in Q1 2025 and has held it in 5 quarters since.
  • Dauntless Investment Group's OKYO Pharma position peaked at $4.84M in Q3 2025.
  • 12 funds tracked by Wall St. Rank held OKYO Pharma as of Q1 2026.

Based on Dauntless Investment Group's 13F filing for Q1 2026, filed 14 May 2026.